Skip to main content
. 2010 May 18;27(8):495–499. doi: 10.1007/s10815-010-9434-3

Table 2.

Demographics and outcome data by type of malignancy

Subdiagnosis Age (y) Estradiol day ovulation trigger (pg/ml) No. mature oocytes cryopreserved
Gynecologic (n = 22) Ovarian (9) 30 (19–40) 2,586 13 (0–33)
Cervical (7)
Endometrial (5)
Vaginal (1)
Breast (n = 12) DCIS (2) 38 (33–43) 1,686 9 (3–26)
Invasive (10)
Hematologic (n = 8) AML (3) 25 (30–34) 3,181 24 (8–40)
Hodgkin’s Lymphoma (HL) (3)
Non-H L (2)
Gastrointestinal (n = 3) Colon (2) 32 (23–37) 990 3 (2–4)
Carcinoid (1)
Central nervous system (n = 2) Brain glioma (1) 28 (27–29) 2,230 11 (6–15)
Spinal cord (1)
Other (n = 3) Rhabdomyosarcoma (1) 28 (27–29) 2,919 23 (11–35)
Thymic (1)
Peritoneal mesothelioma (1)

Values are expressed as means (range)